Keywords: gw, files, relenza, usa, glaxo, wellcome, filed

GW Files Relenza In USA

Article | 28 October 1998

Print This

Glaxo Wellcome has filed for marketing approval of its neuraminidaseinhibitor Relenza (zanamivir) in the USA as a treatment for influenza. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in